Zynex Inc. (ZYXI): Price and Financial Metrics


Zynex Inc. (ZYXI): $12.07

-0.26 (-2.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZYXI POWR Grades


  • ZYXI scores best on the Quality dimension, with a Quality rank ahead of 95.14% of US stocks.
  • The strongest trend for ZYXI is in Growth, which has been heading up over the past 51 weeks.
  • ZYXI's current lowest rank is in the Stability metric (where it is better than 18.05% of US stocks).

ZYXI Stock Summary

  • With a price/earnings ratio of 82.08, Zynex Inc P/E ratio is greater than that of about 90.28% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of 261.24%, Zynex Inc's debt growth rate surpasses 96.2% of about US stocks.
  • Revenue growth over the past 12 months for Zynex Inc comes in at 66.66%, a number that bests 90.2% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Zynex Inc are KNSL, GAIA, LYTS, CLFD, and CVCO.
  • ZYXI's SEC filings can be seen here. And to visit Zynex Inc's official web site, go to www.zynex.com.

ZYXI Valuation Summary

  • ZYXI's price/earnings ratio is 89.3; this is 144.66% higher than that of the median Healthcare stock.
  • ZYXI's price/sales ratio has moved up 4.5 over the prior 178 months.
  • Over the past 178 months, ZYXI's price/earnings ratio has gone up 87.7.

Below are key valuation metrics over time for ZYXI.

Stock Date P/S P/B P/E EV/EBIT
ZYXI 2021-08-31 4.6 8.1 89.3 71.2
ZYXI 2021-08-30 4.6 8.1 89.1 71.1
ZYXI 2021-08-27 4.6 8.1 88.9 71.0
ZYXI 2021-08-26 4.6 8.1 88.4 70.5
ZYXI 2021-08-25 4.8 8.4 92.3 73.7
ZYXI 2021-08-24 4.8 8.4 92.7 74.0

ZYXI Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at 23487.3%.
  • Its 3 year net cashflow from operations growth rate is now at 1106.04%.
  • Its year over year net cashflow from operations growth rate is now at -198.99%.
ZYXI's revenue has moved up $49,276,000 over the prior 15 months.

The table below shows ZYXI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 100.78 -6.743 5.222
2021-03-31 89.021 -5.119 5.431
2020-12-31 80.122 0.818 9.074
2020-09-30 68.679 4.612 10.234
2020-06-30 60.47 7.222 10.934
2020-03-31 51.504 5.171 10.079

ZYXI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZYXI has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
  • ZYXI's asset turnover comes in at 1.385 -- ranking 7th of 185 Medical Equipment stocks.
  • BLFS, NURO, and MASI are the stocks whose asset turnover ratios are most correlated with ZYXI.

The table below shows ZYXI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.385 0.771 0.173
2021-03-31 1.459 0.776 0.254
2020-12-31 1.547 0.783 0.459
2020-09-30 1.683 0.788 0.648
2020-06-30 1.967 0.793 0.802
2020-03-31 1.906 0.797 0.789

ZYXI Price Target

For more insight on analysts targets of ZYXI, see our ZYXI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $26.70 Average Broker Recommendation 1.5 (Moderate Buy)

ZYXI Stock Price Chart Interactive Chart >

Price chart for ZYXI

ZYXI Price/Volume Stats

Current price $12.07 52-week high $22.89
Prev. close $12.33 52-week low $10.66
Day low $12.01 Volume 411,100
Day high $12.99 Avg. volume 399,566
50-day MA $12.71 Dividend yield N/A
200-day MA $15.13 Market Cap 419.55M

Zynex Inc. (ZYXI) Company Bio


Zynex Inc., through its subsidiary, markets electro therapy products which help improve life of patients who have functional disabilities. The Company's products include muscle stimulation, inferential, and TENS devices. Zynex products are intended for home use for stroke rehabilitation, spinal cord injury rehabilitation, incontinence, and other applications.


ZYXI Latest News Stream


Event/Time News Detail
Loading, please wait...

ZYXI Latest Social Stream


Loading social stream, please wait...

View Full ZYXI Social Stream

Latest ZYXI News From Around the Web

Below are the latest news stories about Zynex Inc that investors may wish to consider to help them evaluate ZYXI as an investment opportunity.

Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q3 2021.

Yahoo | October 13, 2021

Zynex to Display its CM-1500 Fluid Monitoring System at the American Society of Anesthesiologists Annual Conference

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that Zynex Monitoring Solutions will attend and display the CM-1500 Fluid Management Device at the American Society of Anesthesiologists Annual Conference from October 8 – 12 in San Diego.

Yahoo | October 8, 2021

Zynex, inc (ZYXI) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. Zynex, inc (NASDAQ: ZYXI)Q2 2021 Earnings CallJul 29, 2021, 4:15 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and welcome to the Zynex 2021 Second Quarter Earnings Call.

Yahoo | July 30, 2021

Zynex Inc. (ZYXI) Surpasses Q2 Earnings Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 14.29% and -0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 29, 2021

Zynex Announces 2021 Second Quarter Earnings

2021 Second Quarter

Yahoo | July 29, 2021

Read More 'ZYXI' Stories Here

ZYXI Price Returns

1-mo -1.63%
3-mo -28.20%
6-mo -22.18%
1-year -14.15%
3-year 286.86%
5-year 5,647.62%
YTD -10.33%
2020 71.03%
2019 167.69%
2018 -7.55%
2017 960.00%
2016 -33.77%

Continue Researching ZYXI

Here are a few links from around the web to help you further your research on Zynex Inc's stock as an investment opportunity:

Zynex Inc (ZYXI) Stock Price | Nasdaq
Zynex Inc (ZYXI) Stock Quote, History and News - Yahoo Finance
Zynex Inc (ZYXI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8567 seconds.